Navegar por término DeCS "tasa de supervivencia"

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

2019- Redondo, A. M.; Valcárcel, D.; González-Rodríguez, A. P.; Suárez-Lledó, M.; Bello López, José Luis; [et al.]

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

2020- Camidge, D Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C H; Han, Ji-Youn; [et al.]

Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2

2020- Gómez Antúnez, M.; Muiño Míguez, A.; Bendala Estrada, A.D.; Maestro de la Calle, G.; Monge Monge, D.; [et al.]

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping

2019- Zugazagoitia, J; Ramos, I; Trigo, J M; Palka, M; Gomez-Rueda, A; [et al.]

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

2019- Lozano, Maria L; Mingot-Castellano, Maria E; Perera, Maria M; Jarque, Isidro; Campos-Alvarez, Rosa M; [et al.]

Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers

2019- Fernández Montes, Ana; Martinez Lago, Nieves Purificacion; Covela Rúa, Marta; De La Cámara Gómez, Juan Cruz; González Villaroel, Paula; [et al.]

Evaluation of Lu-177-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors

2020- ABOU JOKH CASAS, ESTEPHANY; Pubul Nuñez, Virginia; Anido Herranz, Urbano; Mallón Araujo, María del Carmen; Del Pombo Pasín, Maria Carmen; [et al.]

Frailty, disability and comorbidity: different domains lead to different effects after surgical aortic valve replacement in elderly patients

2019- Piñon Esteban, Miguel Angel; Paredes Galán, Emilio; ACUÑA PAIS, BEATRIZ; Raposeiras Roubín, Sergio; CASQUERO VILLACORTA, ELENA; [et al.]

Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

2020- Fernández-Mateos, J.; Pérez-García, J.; Seijas-Tamayo, R.; Mesía, R.; Rubió-Casadevall, J.; [et al.]

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

2019- Elez, Elena; Pericay, Carles; Valladares Ayerbes, Manuel; Bando, Inmaculada; Safont, Maria Jose; [et al.]

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

2019- Rivera, F.; Romero, C.; Jimenez-Fonseca, P.; Izquierdo-Manuel, M.; Salud, A.; [et al.]

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study

2017-06-13- Vidal Insua, Yolanda; De La Cámara Gómez, Juan Cruz; Brozos Vázquez, Elena María; Fernández Montes, Ana; Vázquez Rivera, Francisca; [et al.]

Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

2019- Schmidinger, M.; Bamias, A.; Procopio, G.; Hawkins, R.; Sánchez, AR.; [et al.]

Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study

2020- García-Muñoz, R.; Quero, C.; Pérez-Persona, E.; Domingo-García, A.; Pérez-López, C.; [et al.]

Repositorio digital RUNA

Navegar por término DeCS "tasa de supervivencia"

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group ﻿

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial ﻿

Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2 ﻿

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping ﻿

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia ﻿

Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers ﻿

Evaluation of Lu-177-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors ﻿

Frailty, disability and comorbidity: different domains lead to different effects after surgical aortic valve replacement in elderly patients ﻿

Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial ﻿

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients ﻿

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial ﻿

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study ﻿

Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study) ﻿

Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study ﻿

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers

Evaluation of Lu-177-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors

Frailty, disability and comorbidity: different domains lead to different effects after surgical aortic valve replacement in elderly patients

Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study

Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study